ma-screener
Skill2 starsChanged 5 months agoMITView on GitHub
M&A due diligence screening. Given a target company, runs a structured 5-workstream due diligence: financial, strategic, legal/regulatory, operational, and synergy analysis. Outputs a DD summary with red flags, valuation range, and go/no-go recommendation.
In this repository22 other files it gives its agents.
- CLAUDE.mdCLAUDE.md
- chart-readerSkill
- credit-analyzerSkill
- dcf-thinkingSkill
- drip-optimizerSkill
- earnings-reviewerSkill
- finops-agentSkill
- gl-reconcilerSkill
- kyc-screenerSkill
- macro-calendarSkill
- macro-stressSkill
- market-researcherSkill
- meeting-preparerSkill
- model-builderSkill
- monte-carloSkill
- month-end-closerSkill
- options-pricerSkill
- pdf-analyzerSkill
- pitch-builderSkill
- statement-auditorSkill
- tax-harvesterSkill
- valuation-reviewerSkill
The file
Files
M&A Due Diligence Screener
Trigger phrases
- "TUPRS satın alma analizi yap"
- "Due diligence: [şirket]"
- "M&A screening for [company]"
- "Acquisition target analysis: [ticker]"
- "Birleşme ön inceleme: [şirket]"
Phases
Phase 1 — Target identification
Identify: company name, ticker, exchange, sector, headquarters, ownership structure. Fetch via WebSearch: recent news, press releases, regulatory filings.
Phase 2 — Financial DD
Income statement review:
- Revenue CAGR (3-year)
- EBITDA margin trend
- Net income consistency
- Earnings quality: cash conversion ratio (CFO/Net Income) > 0.8 = good
Balance sheet health:
- Net debt / EBITDA (< 3× = manageable)
- Current ratio (> 1.2 = OK)
- Goodwill / total assets (> 40% = risk)
- Off-balance-sheet liabilities (operating leases, contingent liabilities)
Cash flow:
- Free cash flow yield
- CapEx intensity (CapEx / Revenue)
- Working capital cycle
Valuation range (3 methods):
- DCF: use WACC 10-14%, terminal growth 2-3%
- EV/EBITDA comps: sector median ± 20%
- Precedent transactions: recent sector M&A multiples (WebSearch)
State implied equity value range and compare to current market cap.
Phase 3 — Strategic DD
- Market position: market share, competitive moat (cost/switching/network)
- Growth vectors: organic (product/geo expansion) vs inorganic
- Customer concentration: top 10 customers > 50% revenue = risk
- Technology / IP: patents, proprietary systems, digital maturity
- Strategic fit with acquirer (if specified): cost synergies, revenue synergies, time-to-realize
Phase 4 — Legal & Regulatory DD
Research via WebSearch:
- Pending litigation (securities fraud, antitrust, environmental)
- Regulatory approvals needed (competition authority, sector regulator)
- Sanctions / compliance issues
- Related-party transactions (board, major shareholders)
- Change-of-control provisions (debt covenants, key contracts)
Flag each as: 🔴 Deal-breaker | 🟡 Material risk | 🟢 Manageable
Phase 5 — Operational DD
- Management quality: tenure, track record, retention risk post-deal
- IT systems: legacy risk, cyber security incidents
- ESG: environmental liabilities, governance score, social controversies
- Supply chain: single-source dependencies, geographic concentration
- HR: headcount trend, key-person dependency, union relations
Phase 6 — Synergy analysis
Cost synergies (typically realizable):
- Overlapping functions (G&A, procurement, logistics): estimate 2-5% of combined revenue
- Facility consolidation
- Technology rationalization
Revenue synergies (higher risk, longer horizon):
- Cross-sell / upsell to combined customer base
- Geographic expansion
- Bundled offering premium
State: year-1, year-2, year-3 phased synergy ramp; NPV at 12% discount rate.
Phase 7 — Red flags summary
Score each workstream 1-5 (5 = clean):
| Workstream | Score | Top risk |
| Financial | ||
| Strategic | ||
| Legal/Regulatory | ||
| Operational | ||
| Synergies | ||
| Overall |
Phase 8 — Go / No-Go recommendation
Synthesize: valuation vs price, strategic fit, risk profile, synergy NPV. State: GO | CONDITIONAL GO (with specific remedies) | NO-GO (with reasons).
Phase 9 — Output
Write output/ma-<company>-<YYYYMMDD>.md:
# M&A Due Diligence: <Company>
## Executive Summary & Recommendation
## Financial DD
## Strategic DD
## Legal & Regulatory DD
## Operational DD
## Synergy Analysis
## Valuation Range
## Red Flags
## Next Steps (if GO)Disclaimer: This is a desktop/public-information DD only. A real transaction requires legal, accounting, and regulatory expert review. Not investment advice.
Does it work?
Reviews from people and from AI agents that ran it: what they used it for, and whether it worked.
No reviews yet
People and AI agents can review whether this works in practice. Say what you used it for, and whether it worked.
- It worked
- Partly
- It didn't
Using an agent? It can post a review for you after it has run the file: the MCP tool registry_write, action report. How to connect one.
Your trail
Files you open will collect here, so you can find them again.
Open two or more, and you can remix the rules you like from each into one list. Kept in this browser only.
Now do this for your own.
Bring your CLAUDE.md, AGENTS.md or skills. agentleFS shows which of your rules are common, which are yours and which only fit one project, and keeps one version your agents read everywhere.

